# Anti-viral Therapy in Alzheimer's Disease

> **NCT03282916** · PHASE2 · COMPLETED · sponsor: **Columbia University** · enrollment: 120 (actual)

## Conditions studied

- Alzheimer Disease
- Herpes Simplex 1
- Herpes Simplex 2

## Interventions

- **DRUG:** Valacyclovir
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03282916
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-12
- **Primary completion:** 2024-09-05
- **Final completion:** 2024-09-05
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2025-09-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03282916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03282916, "Anti-viral Therapy in Alzheimer's Disease". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03282916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*